287 related articles for article (PubMed ID: 11703536)
1. Tissue granuloma structure-function in experimental visceral leishmaniasis.
Murray HW
Int J Exp Pathol; 2001 Oct; 82(5):249-67. PubMed ID: 11703536
[TBL] [Abstract][Full Text] [Related]
2. Histopathological and immunohistochemical characterisation of hepatic granulomas in Leishmania donovani-infected BALB/c mice: a time-course study.
Salguero FJ; Garcia-Jimenez WL; Lima I; Seifert K
Parasit Vectors; 2018 Jan; 11(1):73. PubMed ID: 29386047
[TBL] [Abstract][Full Text] [Related]
3. Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver.
Murray HW; Luster AD; Zheng H; Ma X
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795366
[TBL] [Abstract][Full Text] [Related]
4. IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani.
Terrazas C; Varikuti S; Kimble J; Moretti E; Boyaka PN; Satoskar AR
FASEB J; 2016 Mar; 30(3):1135-43. PubMed ID: 26581600
[TBL] [Abstract][Full Text] [Related]
5. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani.
Murray HW; Nathan CF
J Exp Med; 1999 Feb; 189(4):741-6. PubMed ID: 9989990
[TBL] [Abstract][Full Text] [Related]
6. Effector role of blood monocytes in experimental visceral leishmaniasis.
Cervia JS; Rosen H; Murray HW
Infect Immun; 1993 Apr; 61(4):1330-3. PubMed ID: 8454335
[TBL] [Abstract][Full Text] [Related]
7. Visceral Leishmania donovani infection in interleukin-13-/- mice.
Murray HW; Tsai CW; Liu J; Ma X
Infect Immun; 2006 Apr; 74(4):2487-90. PubMed ID: 16552085
[TBL] [Abstract][Full Text] [Related]
8. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
[TBL] [Abstract][Full Text] [Related]
9. Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.
Murray HW; Mitchell-Flack M; Zheng H; Ma X
Infect Immun; 2015 Feb; 83(2):702-12. PubMed ID: 25452549
[TBL] [Abstract][Full Text] [Related]
10. Mononuclear cell recruitment, granuloma assembly, and response to treatment in experimental visceral leishmaniasis: intracellular adhesion molecule 1-dependent and -independent regulation.
Murray HW
Infect Immun; 2000 Nov; 68(11):6294-9. PubMed ID: 11035738
[TBL] [Abstract][Full Text] [Related]
11. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.
Stern JJ; Oca MJ; Rubin BY; Anderson SL; Murray HW
J Immunol; 1988 Jun; 140(11):3971-7. PubMed ID: 3131421
[TBL] [Abstract][Full Text] [Related]
12. Dynamic imaging of experimental Leishmania donovani-induced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8 T cells.
Beattie L; Peltan A; Maroof A; Kirby A; Brown N; Coles M; Smith DF; Kaye PM
PLoS Pathog; 2010 Mar; 6(3):e1000805. PubMed ID: 20300603
[TBL] [Abstract][Full Text] [Related]
13. Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection.
Paun A; Bankoti R; Joshi T; Pitha PM; Stäger S
PLoS Pathog; 2011 Jan; 7(1):e1001246. PubMed ID: 21253574
[TBL] [Abstract][Full Text] [Related]
14. Defect in the tissue cellular immune response: experimental visceral leishmaniasis in euthymic C57BL/6 ep/ep mice.
Squires KE; Kirsch M; Silverstein SC; Acosta A; McElrath MJ; Murray HW
Infect Immun; 1990 Dec; 58(12):3893-8. PubMed ID: 2123825
[TBL] [Abstract][Full Text] [Related]
15. The Schistosoma mansoni hepatic egg granuloma provides a favorable microenvironment for sustained growth of Leishmania donovani.
Hassan MF; Zhang Y; Engwerda CR; Kaye PM; Sharp H; Bickle QD
Am J Pathol; 2006 Sep; 169(3):943-53. PubMed ID: 16936268
[TBL] [Abstract][Full Text] [Related]
16. Transgenic T cell-specific expression of CXCR3 enhances splenic and hepatic T cell accumulation but does not affect the outcome of visceral leishmaniasis.
Varikuti S; Natarajan G; Oghumu S; Sperling RH; Moretti E; Stock J; Papenfuss TL; Satoskar AR
Cell Immunol; 2016 Nov; 309():61-68. PubMed ID: 27614845
[TBL] [Abstract][Full Text] [Related]
17. Multiple host defense defects in failure of C57BL/6 ep/ep (pale ear) mice to resolve visceral Leishmania donovani infection.
Murray HW; Hariprashad J; McDermott DF; Stoeckle MY
Infect Immun; 1996 Jan; 64(1):161-6. PubMed ID: 8557335
[TBL] [Abstract][Full Text] [Related]
18. An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice.
Engwerda CR; Smelt SC; Kaye PM
Exp Parasitol; 1996 Nov; 84(2):195-202. PubMed ID: 8932769
[TBL] [Abstract][Full Text] [Related]
19. Prevention of relapse after chemotherapy in a chronic intracellular infection: mechanisms in experimental visceral leishmaniasis.
Murray HW
J Immunol; 2005 Apr; 174(8):4916-23. PubMed ID: 15814719
[TBL] [Abstract][Full Text] [Related]
20. Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice.
Sato N; Kuziel WA; Melby PC; Reddick RL; Kostecki V; Zhao W; Maeda N; Ahuja SK; Ahuja SS
J Immunol; 1999 Nov; 163(10):5519-25. PubMed ID: 10553079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
